These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6188915)

  • 1. Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S16-20. PubMed ID: 6188915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.
    Aellig WH
    Br J Clin Pharmacol; 1982; 13(Suppl 2):187S-192S. PubMed ID: 6125169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the ISA of pindolol beta 2-adrenoceptor selective?
    Aellig WH; Clark BJ
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):21S-28S. PubMed ID: 2894222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The additional properties of beta adrenoceptor blocking drugs.
    Prichard BN; Tomlinson B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
    Ades PA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
    Hoey A; Jackson C; Pegg G; Sillence M
    Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
    Brodde OE; Schemuth R; Brinkmann M; Wang XL; Daul A; Borchard U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic sympathomimetic activity: clinical fact or fiction?
    Taylor SH
    Am J Cardiol; 1983 Nov; 52(9):16D-26D. PubMed ID: 6139009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
    Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
    Acta Med Scand Suppl; 1982; 665():103-8. PubMed ID: 6760678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
    Brodde OE; Wang XL; O'Hara N; Daul A; Schiess W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S70-3. PubMed ID: 2439825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic beta-receptorblockade: haemodynamic relevance of beta-1-selectivity and ISA during adrenaline infusion.
    Maltbaek N; Rehling M; Tangø M; Trap-Jensen J; Svendsen TL
    Acta Med Scand Suppl; 1983; 677():21-5. PubMed ID: 6142593
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
    Bilski AJ; Hadfield SE; Wale JL
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
    Prichard BN
    Br J Clin Pharmacol; 1978 May; 5(5):379-99. PubMed ID: 26370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
    Nanoff C; Ströher M; Haschkowitz H; Schütz W; Pittner H
    Basic Res Cardiol; 1990; 85(1):88-95. PubMed ID: 1970235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol increases plasma norepinephrine concentration by stimulation of beta 2-adrenoceptors in conscious spontaneously hypertensive rats.
    Keeton TK
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):354-9. PubMed ID: 1700204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.